Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · IEX Real-Time Price · USD
9.57
-0.11 (-1.14%)
At close: Jul 19, 2024, 4:00 PM
9.56
-0.01 (-0.10%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Theravance Biopharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for TBPH stock have an average target of 20.5, with a low estimate of 20 and a high estimate of 21. The average target predicts an increase of 114.21% from the current stock price of 9.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 29, 2024.
Analyst Ratings
The average analyst rating for TBPH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +108.99% | May 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +108.99% | May 14, 2024 |
| BTIG | BTIG | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +119.44% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +108.99% | Aug 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $20 | Strong Buy | Maintains | $19 → $20 | +108.99% | May 9, 2023 |
Financial Forecast
Revenue This Year
73.93M
from 57.42M
Increased by 28.74%
Revenue Next Year
82.89M
from 73.93M
Increased by 12.12%
EPS This Year
-0.66
from -1.00
EPS Next Year
0.13
from -0.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 90.9M | 103.7M | 180.6M | 260.9M | 430.7M |
| Avg | 73.9M | 82.9M | 132.0M | 154.5M | 218.8M |
| Low | 63.5M | 66.3M | 80.4M | 77.9M | 81.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 58.3% | 40.3% | 117.9% | 97.7% | 178.7% |
| Avg | 28.7% | 12.1% | 59.2% | 17.1% | 41.6% |
| Low | 10.6% | -10.3% | -3.0% | -41.0% | -47.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.45 | 1.03 | 2.51 | 2.25 | 4.70 |
| Avg | -0.66 | 0.13 | 0.87 | 1.91 | 3.56 |
| Low | -0.77 | -0.60 | -0.76 | 1.58 | 2.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,894.9% | 157.8% | 146.0% |
| Avg | - | - | 592.9% | 119.4% | 86.1% |
| Low | - | - | - | 81.0% | 28.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.